Eco R1 Capital, LLC Janux Therapeutics, Inc. Transaction History
Eco R1 Capital, LLC
- $2.14 Billion
- Q4 2024
A detailed history of Eco R1 Capital, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 1,469,818 shares of JANX stock, worth $44.7 Million. This represents 3.68% of its overall portfolio holdings.
Number of Shares
1,469,818
Previous 1,469,818
-0.0%
Holding current value
$44.7 Million
Previous $66.8 Million
17.85%
% of portfolio
3.68%
Previous 2.9%
Shares
5 transactions
Others Institutions Holding JANX
# of Institutions
229Shares Held
55.2MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$315 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$108 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$107 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$93.2 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$71.3 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.27B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...